Cargando…
Gastrointestinal and liver manifestations of COVID-19
The novel coronavirus 2 (SARS-CoV-2) has spread worldwide. While patients typically present with fever and symptoms of a respiratory illness, patients have also presented with gastrointestinal symptoms such as diarrhea, vomiting and abdominal pain. In addition, some patients were reported to have li...
Autores principales: | Cheong, Janice, Bartell, Nichoals, Peeraphatdit, Thoetchai, Mosli, Mahmoud, Al-Judaibi, Bandar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7739995/ https://www.ncbi.nlm.nih.gov/pubmed/32367837 http://dx.doi.org/10.4103/sjg.SJG_147_20 |
Ejemplares similares
-
Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol
por: Naksuk, Niyada, et al.
Publicado: (2020) -
Current status of liver transplantation for cholangiocarcinoma
por: Twohig, Patrick, et al.
Publicado: (2022) -
The association between nonselective beta-blockers and portal venous thrombosis in cirrhotic patients: More questions on the horizon
por: Bartell, Nicholas, et al.
Publicado: (2018) -
Beta-blocker therapy in refractory ascites: A steady march towards the truth
por: Bartell, Nicholas, et al.
Publicado: (2022) -
Duct-to-Duct Biliary Anastomosis Yields Similar Outcomes to Roux-en-Y Hepaticojejunostomy in Liver Transplantation for Primary Sclerosing Cholangitis
por: Al-Judaibi, Bandar, et al.
Publicado: (2015)